You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
As adoption of personalized medicines has accelerated over the last four years, so has the number of marketed genetic and exome tests.
The report also identified opportunities to improve adoption through dissemination of evidence supporting the clinical and economic utilization of testing.
Although people have greater access to personalized drugs and tests than ever before, a survey by GenomeWeb and the PMC shows public awareness isn't improving.
The law contains provisions that proponents say will advance precision medicine and speed new tests to market, but critics worry if this will come at a cost to public health.
The group hopes its proposed regulatory framework might strike a compromise between different industry stakeholders.